Study of Lenalidomide as a Treatment for Neuropathy Associated With Monoclonal Gammopathy of Undetermined Significance

Stopped The study has been suspended for slower than anticipated enrollment to date.

Conditions

• Neuropathy
• Nonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS)

Interventions

• DRUG: Lenalidomide

Sponsor

Dartmouth-Hitchcock Medical Center

Collaborators

• [object Object]